Company is still in a strong cash position , multiple trials underway just the wait for data seems endless but the Biotech Gospel is "You can't rush the science" Like many SH could do with some "Interim Data" but we may well see a SH update upon Ninas return ....
- Forums
- ASX - By Stock
- DXB
- Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-11
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
40.0¢ |
Change
-0.010(2.44%) |
Mkt cap ! $220.2M |
Open | High | Low | Value | Volume |
41.5¢ | 42.0¢ | 39.5¢ | $839.4K | 2.070M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 35000 | 39.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
40.0¢ | 83901 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 10000 | 0.395 |
4 | 60000 | 0.390 |
7 | 171788 | 0.385 |
8 | 327657 | 0.380 |
4 | 209342 | 0.375 |
Price($) | Vol. | No. |
---|---|---|
0.400 | 9924 | 2 |
0.410 | 103132 | 2 |
0.415 | 132474 | 5 |
0.420 | 108356 | 2 |
0.425 | 60000 | 2 |
Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |